Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$6.69 - $9.0 $7,078 - $9,522
-1,058 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$8.26 - $11.4 $4,361 - $6,019
528 Added 99.62%
1,058 $7,000
Q4 2020

Jan 13, 2021

BUY
$8.21 - $18.59 $3,300 - $7,473
402 Added 314.06%
530 $4,000
Q3 2020

Nov 12, 2020

SELL
$11.33 - $19.81 $3,920 - $6,854
-346 Reduced 73.0%
128 $2,000
Q2 2020

Aug 13, 2020

BUY
$4.2 - $15.45 $1,990 - $7,323
474 New
474 $5,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.2B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.